After announcing the state would initiate coverage of GLP-1s to combat obesity in September 2022 as part of their state employee health plan, the state reversed course and in January 2025 announced it was opting to end that coverage beginning July 1, 2025
Knudsen was not the only one interested in obesity at Novo Nordisk
Researchers utilise this compound in laboratory models to investigate cellular energy homeostasis and NAD+ salvage pathways
Potential side effects & risks While LCarnitine is generally considered safe when used correctly, there are things to be aware of: Gastrointestinal issues nausea, upset stomach, diarrhea or cramps
The answer lies in a combination of factors that should be considered carefully, from the type of acne scars you have to your skin type, pain tolerance, and budget
Treating them as equivalent is a critical error in research design